Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes

NCT05185518 is registered in ClinicalTrials.gov with Pacific Diabetes Technologies as lead sponsor.

NCT NCT05185518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05185518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes
Lead sponsor
Pacific Diabetes Technologies
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2025
Completion date
February 28, 2026
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes treated with insulin